Publication date: Mar 19, 2020
Increasing evidences support that glial connexins are involved in the demyelination pathology of multiple sclerosis (MS), a chronic inflammatory demyelinating disorder. Here, we review the data from patients with MS and animal models of MS that implicate connexins in demyelination. Connexins expressed in oligodendrocytes and astrocytes show diverse changes at the different phases of MS. Loss of oligodendrocyte or astrocyte connexins contributes to demyelination and exaggerates the pathology of MS. Channel-dependent and -independent connexins are involved in the pathology of demyelination, which is related with myelin integrity, metabolic homeostasis, the brain-blood barrier, the immune cell infiltration, and the inflammatory response. A comprehensive understanding of connexin function in demyelination may provide new therapeutic targets for MS.
Xia, C.Y., Xu, J.K., Pan, C.H., Lian, W.W., Yan, Y., Ma, B.Z., He, J., and Zhang, W.K. Connexins in oligodendrocytes and astrocytes: possible factors for demyelination in multiple sclerosis. 20518. 2020 Neurochem Int.